INAF
Indofarma Tbk.
126
09 Oct 2026
PER
-5,78
PBV
-0,34
ROE
—
Current Ratio
0,09
DER
—
Berdasarkan data Trailing Twelve Months (TTM).
Klasifikasi
Sektor
Kesehatan
Sub Sektor
Farmasi & Riset Kesehatan
Industri
Farmasi
Sub Industri
Farmasi
Business Line
—
Product & Commodity
—
Info Umum
Tanggal Pencatatan
—
Mata Uang
IDR
Website
https://indofarma.id
Email
—
Telepon
—
Alamat
Jalan Indofarma No. 1 - Cikarang Barat, Bekasi
Tentang Perusahaan
PT Indofarma Tbk, together with its subsidiaries, manufactures and markets pharmaceutical products in Indonesia. The company trades in and distributes drugs, medical devices, medical supplies, extracts, and herbals; and operates laboratory. It also provides COVID-19 test services, including rapid diagnostic test antigen; reverse transcription polymerase chain reaction, and genose. The company also exports its products. The company was formerly known as PT Indofarma (Persero) Tbk. PT Indofarma Tbk was founded in 1918 and is headquartered in Bekasi, Indonesia. PT Indofarma Tbk operates as a subsidiary of PT. Bio Farma.
Rasio
Rasio Profitabilitas
Gross Profit Margin (TTM)
-0,82%
Operating Profit Margin (TTM)
-105,65%
Net Profit Margin (TTM)
-41,31%
Management Effectiveness
ROA (TTM)
-10,93%
ROE (TTM)
—
Asset Turnover (TTM)
0,31x
Rasio Liquiditas & Leverage
Current Ratio
0,09
Quick Ratio
0,07
Debt to Equity Ratio (DER)
—
Rasio Aktivitas
Perputaran Aset (TTM)
0,31x
Inventory Turnover (TTM)
2,52x
Receivables Turnover (TTM)
8,75x
Valuasi
Current Valuation
Current PE Ratio (Annual)
-5,01
Current PE Ratio (TTM)
-5,78
Earning Yield (Annual)
-19,97%
Earning Yield (TTM)
-17,30%
Earning Yield (Greenblatt: EBIT/EV)
-0,37%
Current Price to Book Value
-0,34
Current Price to Sales (TTM)
2,39
Current Price to Cashflow (TTM)
-2,69
EV to EBITDA (TTM)
-336,29
Fair Value (Graham Number)
Rugi — Graham Number tidak berlaku
Per Share
EPS (Annual)
-25
EPS (TTM)
-22
Book Value per Share
-369
Revenue per Share (Annual)
49
Revenue per Share (TTM)
53
Cash Flow per Share (Annual)
-7
Cash Flow per Share (TTM)
-47
Ukuran Perusahaan
Market Cap
390,51 M
Enterprise Value
1,09 T
Saham Beredar
3,10 M
Total Aset
535,99 M
Total Ekuitas
-706,94 M
Free Cash Flow (Annual)
-209,98 M
Growth (TTM vs Tahun Terbaru)
Revenue Growth
7,93%
Gross Profit Growth
93,04%
Net Income Growth
13,36%
Screening ala Graham
2 / 9
Bukan Saham Teknologi
Lulus
Termasuk Sektor Kesehatan
Lulus
Revenue Lebih dari Rp175 Miliar
Gagal
Current Ratio > 2
Gagal
Utang Jangka Panjang < Modal Kerja Bersih
Gagal
PER Wajar (< 15)
Gagal
PER x PBV < 22
Gagal
DER Rendah (< 100%)
Gagal
Membagikan Dividen
Gagal
Checklist ala kriteria defensive investor Benjamin Graham — bukan rekomendasi investasi, semata analisis kuantitatif berdasarkan data laporan keuangan terakhir.
Piotroski F-Score
5 / 9
Arus kas operasi positif
Gagal
ROA membaik
Lulus
Rasio utang jangka panjang menurun
Lulus
Kualitas laba (OCF > laba bersih)
Lulus
Laba bersih positif
Gagal
Jumlah saham tidak bertambah
Lulus
Gross margin membaik
Lulus
Current ratio membaik
Gagal
Asset turnover membaik
Gagal
Altman Z-Score
-4.43
Modal Kerja / Total Aset
-0.96
Laba Ditahan / Total Aset
-2.68
EBIT / Total Aset
-0.01
Nilai Pasar Ekuitas / Total Liabilitas
0.31
Penjualan / Total Aset
0.31
Zona
Distress Zone
Model prediksi risiko kebangkrutan Edward Altman (1968) — Z > 2,99 Safe Zone, 1,81–2,99 Grey Zone, di bawah 1,81 Distress Zone.
Graham Valuation
Fair Value (Graham Number)
Rugi — Graham Number tidak berlaku
Harga Saat Ini
126
Selisih
—
Status Kuartal Terkini
Checklist fundamental berbasis TTM & laporan tahunan — label berwarna berarti kriteria terpenuhi.
Kinerja Dasar
Laba
Laba Naik
Laba Naik < 20%
Penjualan Turun < 20%
Hutang Turun < 20%
Pertumbuhan Rata-rata (CAGR)
Modal Naik Rata2 > 10%
Modal Naik Rata2 > 20%
Modal Naik Rata2 > 40%
Penjualan Naik Rata2 > 10%
Laba Naik Rata2 > 20%
Solvabilitas
DER < 0.5x
DER < 1x
Likuiditas
Aset Lancar > Hutang Lancar
Profitabilitas
ROE > 10%
Margin Laba Kotor > 20%
Margin Laba Kotor > 40%
Margin Laba Kotor > 60%
Margin Laba Kotor > 80%
Margin Laba Operasi > 10%
Margin Laba Operasi > 20%
Margin Laba Bersih > 10%
Margin Laba Bersih > 20%
Margin Laba Bersih > 30%
Valuasi
Nilai Buku < Harga
Laba Kotor
264,24 M
2018
400,60 M
2020
451,65 M
2021
-8,52 M
2022
-157,39 M
2023
-37,51 M
2024
-19,22 M
2025
Laba Bersih
-32,74 M
2018
27,58 Jt
2020
-37,58 M
2021
-457,62 M
2022
-720,99 M
2023
-334,49 M
2024
-77,99 M
2025
Margin Laba Kotor
16,6%
2018
23,4%
2020
15,6%
2021
-0,9%
2022
-30,1%
2023
-17,8%
2024
-12,7%
2025
Margin Laba Operasi
-1,4%
2018
3,8%
2020
2,0%
2021
-35,6%
2022
-97,8%
2023
-110,2%
2024
-137,4%
2025
Margin Laba Bersih
-2,1%
2018
0,0%
2020
-1,3%
2021
-46,7%
2022
-137,7%
2023
-159,0%
2024
-51,5%
2025
Imbal Hasil Aset (ROA)
-
2018
-
2020
-1,9%
2021
-30,9%
2022
-94,9%
2023
-54,1%
2024
-14,6%
2025
Imbal Hasil Ekuitas (ROE)
-
2018
-
2020
-7,4%
2021
-
2022
-
2023
-
2024
-
2025
Current Ratio
-
2018
-
2020
1,35x
2021
0,84x
2022
0,16x
2023
0,09x
2024
0,19x
2025
Quick Ratio
-
2018
-
2020
1,03x
2021
0,60x
2022
0,11x
2023
0,07x
2024
0,08x
2025
Debt to Equity Ratio (DER)
-
2018
-
2020
295,8%
2021
-
2022
-
2023
-
2024
-
2025
Perputaran Aset
-
2018
-
2020
1,44x
2021
0,66x
2022
0,69x
2023
0,34x
2024
0,28x
2025
Perputaran Persediaan
-
2018
-
2020
7,34x
2021
4,05x
2022
10,33x
2023
7,44x
2024
2,61x
2025
Perputaran Piutang
-
2018
-
2020
7,65x
2021
5,66x
2022
8,39x
2023
4,82x
2024
8,11x
2025
Tren historis per tahun buku berdasarkan laporan laba rugi & neraca yang tersedia. Batang berwarna merah menandakan nilai negatif.
| Item | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 163.565.873.328 | 151.550.541.801 | 210.379.673.780 | 523.599.087.434 | 980.370.552.490 | 2.901.986.532.879 | 1.715.590.000.000 | 1.592.980.000.000 |
| Cost of Revenue | 164.903.974.820 | 170.767.400.478 | 247.887.351.482 | 680.988.443.517 | 988.892.681.503 | 2.450.332.548.549 | 1.314.990.000.000 | 1.328.750.000.000 |
| Gross Profit | -1.338.101.492 | -19.216.858.677 | -37.507.677.702 | -157.389.356.083 | -8.522.129.013 | 451.653.984.330 | 400.600.000.000 | 264.235.000.000 |
| Operating Expenses | 171.471.181.515 | 189.004.203.619 | 194.290.566.228 | 354.619.436.153 | 340.842.386.853 | 395.108.701.751 | 335.098.000.000 | 1.614.570.000.000 |
| Operating Income | -172.809.283.007 | -208.221.062.296 | -231.798.243.930 | -512.008.792.236 | -349.364.515.866 | 56.545.282.579 | 65.501.287.887 | -21.590.118.706 |
| EBIT | -4.027.882.659 | -41.017.195.939 | -253.743.230.233 | -610.349.752.838 | -511.255.379.905 | — | 0 | -21.590.118.706 |
| Income Before Tax | -60.335.328.336 | -71.455.457.450 | -283.757.708.547 | -669.509.217.512 | -549.336.370.240 | 8.773.199.052 | 18.081.602.176 | -25.298.215.467 |
| Net Income | -67.567.290.524 | -77.989.296.702 | -334.488.574.835 | -720.993.176.197 | -457.624.300.414 | -37.580.639.615 | 27.580.910 | -32.735.901.429 |
| Basic EPS | -21,80 | -25,16 | -107,93 | -232,63 | -147,66 | -12,12 | — | — |
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Aset | 535.988.243.201 | 617.768.889.113 | 759.828.977.658 | 1.481.412.095.840 | 2.011.879.396.142 |
| Aset Lancar | 119.231.963.692 | 133.800.791.544 | 198.991.900.314 | 863.577.052.312 | 1.411.390.099.989 |
| Kas | 5.686.138.621 | 10.114.017.765 | 17.070.939.961 | 269.751.394.924 | 380.814.191.220 |
| Piutang | 18.697.121.143 | 43.650.622.151 | 62.429.133.407 | 173.136.177.340 | 379.499.459.835 |
| Persediaan | 65.551.930.887 | 33.331.370.322 | 65.931.990.227 | 243.968.559.046 | 333.734.190.679 |
| Total Liabilitas | 1.242.930.855.603 | 1.761.810.697.886 | 1.563.981.235.924 | 1.487.737.061.285 | 1.503.569.486.636 |
| Liabilitas Lancar | 632.653.594.525 | 1.506.866.870.074 | 1.231.087.955.072 | 1.025.331.067.523 | 1.045.188.438.355 |
| Long Term Debt | 455.002.552.322 | 215.408.759.812 | 295.653.233.748 | 429.785.960.579 | 394.520.732.587 |
| Total Ekuitas | -706.942.612.402 | -1.144.019.856.886 | -804.133.826.522 | -6.313.423.902 | 508.295.782.392 |
| Working Capital | -513.421.630.833 | -1.373.066.078.530 | -1.032.096.054.758 | -161.754.015.211 | 366.201.661.634 |
| Item | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Kas dari Aktivitas Operasi | -190.883.735.882 | -209.981.609.137 | -21.653.684.335 | -194.130.706.225 | -75.946.136.115 | 0 |
| Kas dari Aktivitas Investasi | 71.432.033 | 91.509.795 | -319.810.489 | -657.117.940 | -13.397.332.921 | 0 |
| Kas dari Aktivitas Pembiayaan | 189.864.761.174 | 206.321.492.861 | 14.983.403.412 | -57.850.265.915 | 13.327.575.869 | 0 |
| Capital Expenditures | 0 | 0 | -425.750.269 | -4.738.223.680 | -13.475.982.593 | -21.404.145.384 |
| Arus Kas Bebas (FCF) | -190.883.735.882 | -209.981.609.137 | -22.079.434.604 | -198.868.929.905 | -89.422.118.708 | 0 |
| Dividen Dibayar | — | — | — | — | — | — |